Weiyi Liu
Xiyuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Comparative efficacy and hematologic safety of different dosages of JAK inhibitors in the treatment of myelofibrosis: a network meta-analysis.
Journal: Frontiers in oncology
Published: March 20, 2024
Activated PRKCD-mediated neutrophil extracellular traps pathway may be the prothrombotic mechanism of neutrophils in polycythemia vera patients based on clinical retrospective analysis and bioinformatics study.
Journal: International immunopharmacology
Published: September 07, 2023
Incidence of Thrombosis at Different Sites During the Follow-Up Period in Essential Thrombocythemia: A Systematic Review and Meta-Analysis.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: June 23, 2023
Proteomic-Based Platelet Activation-Associated Protein SELP May Be a Novel Biomarker for Coagulation and Prognostic in Essential Thrombocythemia.
Journal: Journal of clinical medicine
Published: November 18, 2022
Coagulation status and determinants of possible aspirin resistance in patients with essential thrombocythemia.
Journal: Frontiers in medicine
Published: November 07, 2022
TET2 Mutation May Be More Valuable in Predicting Thrombosis in ET Patients Compared to PV Patients: A Preliminary Report.
Journal: Journal of clinical medicine
Published: October 08, 2022
Metabolic Biomarkers Affecting Cell Proliferation and Prognosis in Polycythemia Vera.
Journal: Cancers
Published: August 28, 2022
The efficiency and safety of Shengxuening tablet on treating and preventing iron deficiency anemia: A systematic review and meta-analysis.
Journal: Frontiers in pharmacology
Published: August 27, 2022
Arsenic Dispensing Powder Promotes Erythropoiesis in Myelodysplastic Syndromes via Downregulation of HIF1A and Upregulation of GATA Factors.
Journal: The American journal of Chinese medicine
Published: March 01, 2021
Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis.
Journal: Annals of hematology
Published: November 22, 2020
Ruxolitinib-based combinations in the treatment of myelofibrosis: worth looking forward to.
Journal: Annals of hematology
Published: March 06, 2020
Last Updated: 09/26/2026